Mumbai
08048034404
+918506873687

Dr. Chetan Kalal’s latest service update

Dr. Chetan Kalal’s latest service update highlights a shift toward early transplant evaluation, personalized planning, and multidisciplinary care pathways—ensuring patients with advanced liver disease receive timely, evidence-based interventions. This new algorithm emphasizes proactive monitoring, donor counseling, and global-standard aftercare.


🔑 Key Updates in Service Algorithm

  • Early Evaluation 
    Patients with decompensated cirrhosis, rising MELD scores, or recurrent complications are now assessed earlier to avoid emergency admissions.
  • Personalized Planning 
    Tailored transplant readiness protocols, including MELD-based monitoring and donor counseling, are integrated into care.
  • Multidisciplinary Approach 
    Hepatologists, surgeons, nutritionists, psychologists, and coordinators collaborate for seamless patient management.
  • Living Donor Pathways 
    Patients are encouraged to explore LDLT options early alongside DDLT listings to reduce waitlist risks.
  • Global Virtual Consults 
    Available for patients in the US, UK, UAE, Singapore, Canada, Australia, and across Asia-Pacific.

📋 Service Areas Covered

  • Advanced Hepatology Care: Fatty liver disease (NAFLD/NASH/MASLD), cirrhosis, acute liver failure, autoimmune liver disorders.
  • Transplant Expertise: Pre-transplant evaluation, complex eligibility assessment, high-risk optimization, post-transplant care, rejection surveillance.
  • Second Opinions: For failed treatments, unclear diagnoses, transplant confusion, or persistent abnormal liver tests.
  • Critical Care Hepatology: ICU/IPD management for complicated cases.

📍 Location & Access

  • Clinic Address: 35, Dr Ernest Borges Rd, Opp. Shirodkar High School, Parel East, Mumbai, Maharashtra 400012.
  • Appointments: Available in Mumbai and via teleconsultation for international patients.
  • Contact: dr.chetankalal@gmail.com

⚠️ Risks & Considerations

  • Delayed referral often leads to poor surgical fitness and limited donor options.
  • Overdiagnosis risk: Not every abnormal liver test requires aggressive treatment; Dr. Kalal emphasizes rational interpretation.
  • Global coordination challenges: International patients must align logistics for donor availability and aftercare.

📊 Comparison Table: Old vs New Algorithm

AspectPrevious ApproachNew Algorithm Update
Evaluation TimingOften late-stageEarly outpatient evaluation
Donor PathwaysFocus on DDLTEarly LDLT + DDLT
Care ModelPhysician-ledMultidisciplinary team
Referral ProtocolsEmergency-drivenOPD-based readiness
AftercareStandard monitoringGlobal-standard long-term care


 2026-06-02T06:41:36

Other Pages

View all pages